GSTP1 and breast cancer: In summary, in this carefully designed and conducted study of genetic predictors of acute side effects from radiation therapy following lumpectomy for breast cancer, we found that women with GSTP1 genotypes encoding lower activity were more likely to experience toxicity of grade 2c and above.